Author

Twin- And Triple-acting Agents For Treating Core And Co-morbid Signs Of Significant Anxiety: Unique Concepts, Brand-new Drugs

Several encouraging brand-new targets are presently being assessed, such as amylin analogues (pramlintide, davalintide), leptin analogues (metreleptin), GLP-1 analogues (exenatide, liraglutide, TTP-054), MC4R agonists (RM-493), oxyntomodulin analogues, neuropeptide Y antagonists (velneperit), cannabinoid type-1 receptor … Because of drug scarcities and need for weight reduction medications, it is very important to obtain medicines from trustworthy resources […]